Astera Labs, Inc. $ALAB Shares Sold by Pier 88 Investment Partners LLC

Pier 88 Investment Partners LLC reduced its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 76.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,000 shares of the company’s stock after selling 9,640 shares during the period. Pier 88 Investment Partners LLC’s holdings in Astera Labs were worth $587,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the business. Bernard Wealth Management Corp. purchased a new stake in Astera Labs during the 2nd quarter worth about $36,000. Clearstead Trust LLC raised its position in shares of Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after acquiring an additional 461 shares in the last quarter. Advisors Asset Management Inc. lifted its stake in Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after purchasing an additional 194 shares during the last quarter. Manchester Capital Management LLC lifted its stake in Astera Labs by 141.5% during the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after purchasing an additional 283 shares during the last quarter. Finally, Whittier Trust Co. acquired a new position in Astera Labs in the third quarter valued at approximately $55,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Activity

In other news, CEO Jitendra Mohan sold 90,459 shares of the firm’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief executive officer owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. This trade represents a 4.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Philip Mazzara sold 4,620 shares of Astera Labs stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares in the company, valued at approximately $21,275,217.60. The trade was a 3.05% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 576,936 shares of company stock valued at $87,409,540. 12.50% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ALAB shares. BNP Paribas Exane began coverage on shares of Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating on the stock. Bank of America began coverage on shares of Astera Labs in a research note on Friday, October 3rd. They set a “neutral” rating and a $230.00 price target on the stock. Barclays set a $165.00 price target on shares of Astera Labs in a research report on Thursday, January 15th. Northland Securities raised their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Finally, Needham & Company LLC boosted their target price on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $190.63.

Astera Labs Stock Performance

Shares of ALAB opened at $163.25 on Tuesday. The company has a market capitalization of $27.57 billion, a price-to-earnings ratio of 147.07, a price-to-earnings-growth ratio of 2.31 and a beta of 1.50. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The firm has a 50-day simple moving average of $162.24 and a 200-day simple moving average of $170.29.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm’s revenue for the quarter was up 103.9% on a year-over-year basis. During the same period last year, the firm earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.